Brolucizumab for treating neovascular age-related macular degeneration: An alternative for treatment-refractory patients

被引：0
|
作者：
Groen, Martin Biilmann [1 ]
Vestergaard, Anders Hojslet [1 ,2 ]
Cehofski, Lasse Jorgensen [1 ,2 ]
机构：
[1] Odense Univ Hosp, Dept Ophthalmol, Odense, Denmark
[2] Univ Southern Denmark, Clin Inst, Res Unit Ophthalmol, Odense, Denmark
来源：
ACTA OPHTHALMOLOGICA | 2025年
关键词：
D O I：
10.1111/aos.17446
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Brolucizumab: an evolution in treatment for neovascular age-related macular degeneration
    Ong, Ee Lin
    Spooner, Kimberly
    Hong, Thomas
    Chang, Andrew
    EXPERT REVIEW OF OPHTHALMOLOGY, 2020, 15 (02) : 71 - 81
  • [2] Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration
    Hikaru Ota
    Jun Takeuchi
    Yuyako Nakano
    Etsuyo Horiguchi
    Yosuke Taki
    Yasuki Ito
    Hiroko Terasaki
    Koji M. Nishiguchi
    Keiko Kataoka
    Japanese Journal of Ophthalmology, 2022, 66 : 278 - 284
  • [3] Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration
    Ota, Hikaru
    Takeuchi, Jun
    Nakano, Yuyako
    Horiguchi, Etsuyo
    Taki, Yosuke
    Ito, Yasuki
    Terasaki, Hiroko
    Nishiguchi, Koji M.
    Kataoka, Keiko
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2022, 66 (03) : 278 - 284
  • [4] Efficacy of switching to brolucizumab for neovascular age-related macular degeneration refractory to faricimab
    Hoshino, Junki
    Matsumoto, Hidetaka
    Nakamura, Kosuke
    Akiyama, Hideo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2025, : 221 - 229
  • [5] Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
    Yannuzzi, Nicolas A.
    Freund, K. Bailey
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1323 - 1329
  • [6] Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
    Enriquez, Ana Bety
    Baumal, Caroline R.
    Crane, Ashley M.
    Witkin, Andre J.
    Lally, David R.
    Liang, Michelle C.
    Enriquez, Jose Ramon
    Eichenbaum, David A.
    JAMA OPHTHALMOLOGY, 2021, 139 (04) : 441 - 448
  • [7] The Effectiveness of Brolucizumab and Aflibercept in Patients with Neovascular Age-Related Macular Degeneration
    Musial-Kopiejka, Magdalena
    Polanowska, Katarzyna
    Dobrowolski, Dariusz
    Krysik, Katarzyna
    Wylegala, Edward
    Grabarek, Beniamin Oskar
    Lyssek-Boron, Anita
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (04)
  • [8] Clinical Outcomes of Intravitreal Brolucizumab Injection for Refractory Neovascular Age-related Macular Degeneration
    Lee, Jun Young
    Park, No Hae
    Kwon, Han Jo
    Park, Sung Who
    Byon, Ik Soo
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (09): : 596 - 604
  • [9] Brolucizumab for Neovascular Age-Related Macular Degeneration (BEL Study)
    Van Cleemput, Liesbeth
    Peeters, Freya
    Jacob, Julie
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 1077 - 1085
  • [10] First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration
    Abdin, Alaa Din
    Aljundi, Wissam
    El Jawhari, Khalil
    Suffo, Shady
    Weinstein, Isabel
    Seitz, Berthold
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345